Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: July 31, 2026
Reporting Period: As of the close of business on July 31, 2026
Key Financial Metrics
This filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on capital structure changes.
| Metric | Value |
|---|---|
| Outstanding Common Shares | 3,018,188 |
| Trading Symbol | INBS (Nasdaq) |
Material Changes
The total number of outstanding shares increased to 3,018,188 as of July 31, 2026, due to the following events:
- Sale of shares pursuant to the At The Market Offering Agreement with Ladenburg Thalmann & Co. Inc. (dated September 18, 2024).
- Exercise of previously disclosed outstanding warrants to purchase common stock.
- Issuance of restricted common stock under the Investor Relations and Corporate Development Advisory Agreement with ClearThink Capital Partners LLC (dated February 29, 2024).
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a notification of share count updates under Item 8.01 (Other Events).
Investor Verification Checklist
- Verify the exact number of shares issued under the At The Market Offering Agreement since the last report.
- Confirm the number of warrants exercised during the period.
- Review the terms of the advisory agreement with ClearThink Capital Partners LLC to understand the vesting or restrictions on the newly issued shares.
- Check subsequent filings for updated financial statements reflecting the dilution from these issuances.